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AbstrACt
Objectives Explore the impact of changes to 
commissioning introduced in England by the Health and 
Social Care Act 2012 (HSCA) on cervical screening activity 
in areas identified empirically as particularly affected 
organisationally by the reforms.
Methods Qualitative followed by quantitative methods. 
Qualitative: semi-structured interviews (with NHS 
commissioners, managers, clinicians, senior administrative 
staff from Clinical Commissioning Groups (CCGs), local 
authorities, service providers), observations of commissioning 
meetings in two metropolitan areas of England. Quantitative: 
triple-difference analysis of national administrative data. 
Variability in the expected effects of HSCA on commissioning 
was measured by comparing CCGs working with one local 
authority with CCGs working with multiple local authorities. 
To control for unmeasured confounders, differential changes 
over time in cervical screening rates (among women, 25–64 
years) between CCGs more and less likely to have been 
affected by HSCA commissioning organisational change were 
compared with another outcome—unassisted birth rates—
largely unaffected by HSCA changes.
results Interviewees identified that cervical screening 
commissioning and provision was more complex and 
‘fragmented’, with responsibilities less certain, following 
the HSCA. Interviewees predicted this would reduce 
cervical screening rates in some areas more than others. 
Quantitative findings supported these predictions. 
Areas where CCGs dealt with multiple local authorities 
experienced a larger decline in cervical screening rates 
(1.4%) than those dealing with one local authority (1.0%). 
Over the same period, unassisted deliveries decreased by 
1.6% and 2.0%, respectively, in the two groups.
Conclusions Arrangements for commissioning and 
delivering cervical screening were disrupted and made 
more complex by the HSCA. Areas most affected saw a 
greater decline in screening rates than others. The fact 
that this was identified qualitatively and then confirmed 
quantitatively strengthens this finding. The study suggests 
large-scale health system reforms may have unintended 
consequences, and that complex commissioning 
arrangements may be problematic.
IntrOduCtIOn  
Structural reorganisations of publicly 
financed healthcare systems, driven by 
central government or other state agencies, 
are frequently employed with the objective 
of improving healthcare delivery, and thus 
population health outcomes, while reducing 
or containing costs.1 However, such endeav-
ours can be disruptive and expensive.2 It 
is important to understand what possible 
impacts these reorganisations have in order 
to understand their value.3 
In the English National Health Service 
(NHS), attempts to evaluate the impact of 
reorganisations have typically used opera-
tional indicators (eg, bed availability, number 
of staff) and measures of clinical activity 
because their improvement was the stated 
goal of government policy (eg, The NHS 
Plan4). Other studies have attempted to 
assess the impacts of reforms by measuring 
their effects on prices, quality and quan-
tity of provision.5 Most studies have relied 
strengths and limitations of this study
 ► Few studies have investigated in detail the impacts 
of large-scale health system change.
 ► This study combines detailed qualitative data ex-
ploring impacts on the system with quantitative ex-
ploration of important outcomes, supporting causal 
inference.
 ► Based on qualitative findings, we developed a quan-
titative measure for assessing the extent of disrup-
tion to the English NHS commissioning system as a 
result of the 2012 Health and Social Care Act.
 ► We found that cervical screening rates decreased 
more post-Act in areas that had experienced higher 
levels of disruption.
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on quantitative analysis of measures that were explicitly 
targeted by policy reforms. There is a need for approaches 
which combine qualitative and quantitative methods to 
generate a deeper understanding of the impacts of struc-
tural reorganisation.6
The most recent structural reorganisation of the 
English NHS, the Health and Social Care Act7 (hereafter 
‘HSCA’ or ‘the Act’), was introduced in April 2013 and 
included wide-ranging changes to the health services 
commissioning system. We explore whether changes to 
the commissioning of cervical screening services resulting 
from the Act affected uptake. This analysis uses a relatively 
novel mixed methods approach. An initial ‘bottom-up’ 
qualitative analysis allowed us to identify problematic 
issues associated with the HSCA for those working locally 
in the health service commissioning system. This process 
highlighted the disruption to established commissioning 
arrangements and cervical screening as a clinical activity, 
which may be specifically affected by this disruption. We 
then developed a quantitative investigation to explore 
this more fully. Together these analyses allow us to infer 
causation.
the HsCA and changes to cervical screening commissioning
The HSCA is regarded as one of the most wide-
ranging legislative reforms in the history of the English 
NHS.8 Primary Care Trusts (PCTs), 152 organisations 
previously responsible for the commissioning of primary, 
community and secondary health services from providers 
on behalf of local populations, were abolished. Their 
commissioning functions were split between three groups 
of organisations: 211 (now 195) newly created Clinical 
Commissioning Groups (CCGs), membership organi-
sations constituted by general practitioner (GP) (family 
doctor) practices, given responsibility for commissioning 
services for their local populations; NHS England (NHSE), 
a new arm’s-length governmental body with responsibility 
for authorising and assessing CCGs and commissioning 
some services at a national level; and top-tier and single-
tier elected local authorities, which took responsibility 
for the majority of public health services for the first time 
since 1974. In addition, Public Health England (PHE) 
was created as an executive agency of the Department of 
Health, to unify the diverse public health profession and 
provide expert support for local public health services.
In some service areas, the transfer of commissioning 
responsibilities was relatively straightforward (eg, the 
commissioning of routine orthopaedic surgery was passed 
from PCTs to CCGs with minimal alteration to the bundle 
of services involved). In other service areas, the transfers 
were much more complex, particularly the commissioning 
of national screening programmes and sexual health 
services, as a result of changes to public health commis-
sioning. Pre-HSCA, national screening programmes and 
sexual health services were both commissioned by PCTs. 
Cervical screening was largely provided by GP practices, 
which received additional funding linked to levels of 
activity,9 but some women opted to have their cervical 
smears in PCT-commissioned sexual health clinics. Post-
HSCA, responsibility for public health services, including 
most sexual health services, was transferred to local 
authorities. The underlying programme theory (ie, the 
explicit expectation about how the policy would work10) 
was that local authorities would be better placed to address 
the wider determinants of health and well-being than the 
NHS because they could link public health services with 
their existing responsibilities, such as for transport and 
housing.11 NHSE took responsibility for commissioning 
national screening programmes.8 NHSE’s regional 
teams are responsible for commissioning screening 
programmes, supported by PHE staff ‘embedded’ within 
NHSE’s screening and immunisation teams.12 There was 
no identifiable underlying programme theory for this 
specific change to screening programme commissioning. 
However, it is notable that, in contrast to the emphasis 
placed on localism associated with the creation of CCGs 
and with the transfer of public health to local authorities, 
screening commissioning became more centralised as a 
consequence of the HSCA.
Table 1 shows the organisations with responsibilities 
of relevance to the commissioning of sexual health, 
including cervical cancer screening services, pre-HSCA 
and post-HSCA. It illustrates how responsibility for such 
services, previously commissioned by PCTs, was split 
between different agencies. This increased complexity 
and fragmentation of responsibilities had the potential to 
disrupt service commissioning.13
This analysis comes from a study designed to foster 
emergent interplay between qualitative and quantitative 
data analysis.14 15 The focus on cervical screening was 
not established at the project design stage but driven by 
the initial qualitative interview findings related to sexual 
health commissioning arrangements and screening 
activity post-HSCA. These findings prompted us to 
consider a quantitative exploration of predictions made 
by interviewees relating to potential changes in cervical 
screening activity.
MetHOds
study context and design
This analysis forms part of a longitudinal project, with 
data collected between January 2015 and December 
2017, into the effect of the HSCA on the commissioning 
system in England. We combined a qualitative and quan-
titative exploration of the commissioning of services in 
two large, socioeconomically diverse metropolitan areas 
of England with a national level quantitative study of 
commissioning outcomes. We used a sequential mixed 
methods approach in which initial qualitative data collec-
tion and analysis were used to shape an ensuing quantita-
tive analysis using routinely available data. We therefore 
present the qualitative and quantitative methods and 
findings in the order undertaken, and integrate them in 
the 'Discussion' section.
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Patient and public involvement
Our interest in exploring the impact of systemic commis-
sioning change on cervical screening rates was driven 
initially by concerns expressed by interviewees about 
potentially negative consequences for patients relating 
to new arrangements. Patients were not directly involved 
in the design of, or recruitment to, the overarching 
project, but an advisory group including a patient repre-
sentative met regularly throughout the project and 
played an important role in supporting its development. 
We presented our initial qualitative findings relating 
to cervical screening, and early ideas for developing a 
mixed methods investigation, to our advisory group and 
were encouraged by our patient representative to pursue 
this. The results of the broader project were disseminated 
to participants, and the advisory group, in the form of 
a series of short reports focusing on specific areas of 
commissioning and the final report.
Qualitative component
Setting, participants, sampling and data collection
The qualitative component took place between March 
2015 and August 2017, focussing on two metropolitan 
‘health economies’ covering a geographical popula-
tion and a group of commissioning organisations and 
providers with close operational links. Across both areas, 
we conducted 143 interviews (each typically an hour in 
length), 93 of which related to sexual health commis-
sioning, with clinical and non-clinical commissioners, 
managers, clinicians and senior administrative staff 
from CCGs, local authorities, service providers and third 
sector organisations. Organisations and participants were 
sampled purposively for variation in type and role. We 
identified participants through organisational websites, 
personal contacts and through ‘snowballing’ in which we 
asked participants to recommend other potential partic-
ipants. Additionally, 8 hours of meetings of an interor-
ganisational sexual health coordinating group involving 
sexual health commissioners and providers were observed 
in one of the areas.
Interviews focused on the commissioning system 
pre-HSCA and post-HSCA, exploring continuities 
and changes to personal and organisational roles, key 
issues and challenges, accountability and performance 
management, interorganisational relationships and 
communication and commissioning decision-making. 
Interviews took place either in person (usually in partici-
pants’ offices) or over the telephone. All interviews were 
audio-recorded and all interviewees were provided with 
written information about the study before consenting 
to participate.
Data analysis
Audio recordings of interviews were transcribed verbatim, 
and observational notes from meetings were produced 
contemporaneously. Transcripts and observational notes 
were imported into NVivo V.10 software and analysed 
thematically by JH and AH.16 This involved repeated 
readings of transcripts to become sufficiently familiar 
with their contents, identifying initial codes and coding 
chunks of data, searching for themes and then itera-
tively defining and reconstituting themes. Our findings 
(see below) contained some predictions made by partic-
ipants regarding changes in cervical screening activity as 
a consequence of the Act. This prompted us to explore 
these predictions in a quantitative analysis, which we now 
describe.
Table 1 Organisations of significance to the commissioning of cervical screening pre-HSCA and post-HSCA
Pre-HSCA
Primary Care Trusts Responsible for all public health commissioning, including sexual health services; 
responsible for commissioning national screening programmes, including cervical 
screening.
UK National Screening Committee Provision of advice and support to NHS organisations on population screening 
programmes.
Post-HSCA
Local authorities Responsible for most public health commissioning, including most sexual health 
services (contraception over and above GP contract, testing and treatment of sexually 
transmitted infections, sexual health advice and promotion).
NHS England (NHSE) Responsible for commissioning national screening programmes, including cervical 
screening, and some sexual health services (notably contraception through GP 
contract, and HIV treatment).
Public Health England (PHE) (including National 
Screening Committee)
Hosts UK National Screening Committee secretariat, which retains the same role; PHE 
staff embedded in subregional NHSE screening and immunisation teams to provide 
expertise and ‘leadership’.
Clinical Commissioning Groups (CCGs) Responsible for improving clinical outcomes for their patients and prevent premature 
death (as part of the NHS Outcomes Framework, which CCGs are held to account on 
by NHSE); GP members are funded to carry out cervical screening through the GP 
contract.
GP, general practitioner; HSCA, Health and Social Care Act 2012. 
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Quantitative component
Interviewees identified that the HSCA had introduced 
confusion over responsibility for the commissioning of 
cervical screening services, and had increased variability 
of provision. They hypothesised that cervical screening 
rates might be reduced by the new commissioning 
arrangements; this prompted discussions among the 
research team and advisory group about developing a way 
of testing these predictions quantitatively as far as routine 
data would permit. As the Act had been implemented in 
all areas simultaneously, removing the scope for a quasi-ex-
perimental approach, we sought to identify a measure 
of variability in the extent to which the Act would have 
been expected to make commissioning more difficult in 
each area. One of the features of the post-HSCA system 
was that some, but not all, CCGs were established which 
crossed local authority boundaries. Some CCGs related to 
as many as three separate local authorities. Local author-
ities were now directly involved in sexual health services 
commissioning. Findings revealed that CCGs experienced 
extra challenges when they had to engage with more than 
one local authority. This suggested that the burden of 
additional interorganisational coordination might have 
consequences for commissioning.
As each local authority developed its own approach 
to cervical screening in its local sexual health clinics, we 
explored the possibility that GP practices located in CCGs 
which had to work with more than one local authority 
might experience lower screening rates compared with 
practices located in CCGs which had only to deal with 
one local authority. We compare the demographic char-
acteristics of these two groups in table 2. The 89 CCGs 
dealing with more than one local authority had a slightly 
older population profile than the 119 CCGs which dealt 
with only one local authority but were otherwise highly 
comparable.
Because cervical screening rates may be influenced by 
other factors that we cannot observe and may change over 
time in different ways between the two groups of CCGs, 
we also compared screening rates with an outcome that 
was unlikely to have been affected by the introduction of 
the HSCA. We used unassisted births (ie, uncomplicated 
deliveries which did not require any intervention) as a 
percentage of all maternal deliveries, since the commis-
sioning of maternity services was largely unchanged by 
the Act.
We applied a triple-difference approach. The triple 
difference represents (the change over time in cervical 
screening rates for CCGs working with only one local 
authority minus the change over time in cervical 
screening rates for CCGs working with more than one 
local authority) minus (the change over time in unassisted 
birth rates for CCGs working with only one local authority 
minus the change over time in unassisted birth rates for 
CCGs working with more than one local authority).
The screening rate is defined as the percentage of 
women aged between 25 and 64 years who had received 
a cervical screening test in the preceding 5 years. This 
indicator was derived from annual, practice-level data 
from the Quality and Outcomes Framework, 2009–10 to 
2015–16. The comparison indicator is unassisted births 
as a percentage of all maternal deliveries. This indicator 
was produced using operation codes in Hospital Episode 
Statistics for 2009–10 to 2015–16. We aggregated the 
spell-level data by general practice and financial year.
The key assumption underpinning the triple-difference 
estimator is that, conditional on the other variables in 
the model, the differences in the changes over time in 
the intervention indicator (cervical screening) between 
the ‘exposed’ and the ‘control’ areas (in this case, 
CCGs working with one local authority vs CCGs working 
with more than one) would have been the same as the 
differences in the changes over time in the comparison 
indicator (unassisted births) between the exposed and 
control areas in the absence of the intervention. This is a 
more complex version of the ‘parallel trends’ assumption 
required for the double-difference, or difference-in-dif-
ferences, estimator.17
A popular test of this assumption in the double-differ-
ence case is that there are parallel trends over time in 
the outcomes in the intervention and comparison group 
in the preintervention period. For our triple-difference 
case, we used an F-test to assess the joint significance of 
interactions between the year effects and the binary vari-
able representing the combination of exposed area and 
treated indicator in the preperiod.
We also used the lagged dependent variable (LDV) 
estimator. This model is estimated only on data in the 
postintervention period and is a less biased estimator 
of treatment effects when the assumption of parallel 
pretrends does not hold.18 We set up the LDV model to 
generate the equivalent impact estimate as the triple-dif-
ference model. The model included: dummy variables 
for year; values of the dependent variable in each of the 
preintervention periods; a dummy variable classifying 
practices depending on whether they were located in 
Table 2 Clinical Commissioning Group (CCG) demographic 
characteristics depending on the number of local authorities 
that the CCG needs to work with
One local 
authority
More than one 
local authority
Number of CCGs 119 89
Population 
(millions)
29.5 26.9
Female 50.0% 50.5%
Age (years)
  0–9 12.3% 11.4%
  10–19 11.2% 11.2%
  20–39 30.0% 24.8%
  40–59 26.5% 27.7%
  60–79 16.0% 19.7%
  80 and above 4.1% 5.3%
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CCGs working with more than one local authority; inter-
actions between year and condition dummies; interac-
tions between values of the dependent variable in the 
preintervention period and the condition dummy and an 
interaction between the dummy variable classifying prac-
tices depending on whether they were located in CCGs 
working with more than one local authority and the 
condition dummy. The final term is the impact estimate, 
showing whether cervical screening was differentially 
affected after the introduction of the reforms for local 
authorities working with multiple CCGs.
We estimated the regression models in Stata V.14.1 
using dummy variable weighted least squares regression 
with fixed effects for practice-indicator combinations. 
The ways in which these models are estimated using 
regression analyses are described formally in the tech-
nical online supplementary appendix. As the dependent 
variable is a proportion, and constrained to lie between 
0 and 1, we used the empirical logit transformation and 
back-transformed the coefficients and associated 95% CIs 
using the mean value of the cervical screening rate.19 We 
clustered the SEs at the GP practice level.20 The general 
form of the STATA command is: areg {depvar} {indepvars} 
[aw=denom], robust absorb(practicexindicator) cluster(practice).
results
Qualitative findings
Interviewees told us that CCGs working with more than 
one local authority experienced a number of chal-
lenges, including: finding sufficient capacity to engage in 
multiple meetings of the same type with different local 
authorities; managing additional collaborative relation-
ships; working with organisations experiencing different 
financial pressures from each other with different 
approaches to public health spending; and attempting to 
develop integrated health and social care arrangements 
with one local authority that did not have unintended 
and undesirable consequences for plans with another. 
The following extract illustrates issues relating to difficul-
ties commissioning a single service offer for CCG patients 
and the additional resources required for a CCG working 
with multiple local authorities. (Interview data extracts 
are denoted by square brackets with numerical partici-
pant ID, participant’s organisation type, Area (1 or 2) and 
month and year of the interview.)
We do have two sets of safeguarding arrangements. So 
I guess at one level, one can say there is a risk of and 
there are examples of services being subtly different. 
Equally, you've got to service two times the number of 
these processes, which can be quite labour-intensive. 
[2778, CCG, Area 1, April 2015]
In our analysis relating directly to issues surrounding 
the commissioning and provision of cervical screening 
post-HSCA, we identified two main themes: confusion 
and uncertainty regarding budgets and responsibilities, 
and potential impacts on cervical screening rates. Many 
of the issues discussed below are likely to be exacerbated 
when the number of interacting commissioning organisa-
tions in a local area are increased.
Confusion and uncertainty regarding budgets and responsibilities
Before the HSCA, both cervical screening and sexual 
health services were commissioned by PCTs. As one 
screening and immunisation lead outlined, cervical 
screening tests (sometimes referred to as smear tests) 
were provided by GP practices, but patients could usually 
also have them at sexual health clinics [17685, NHSE, 
Area 2, December 2016]. Whereas pre-HSCA PCTs held 
the budget for both cervical screening and sexual health 
services, following the Act these budgets were separated. 
This meant that the local authority budget and respon-
sibility for sexual health did not extend to cervical 
screening. One local authority public health consultant 
reported that, in spite of this, PHE was sending letters to 
patients explicitly stating that they could choose to attend 
either their GP practice or their local sexual health clinic 
for their cervical screening test. This highlights confusion 
regarding commissioning arrangements and budgetary 
responsibility:
Public Health England were writing around to people 
saying …you're due your smear, you can go to your 
general practice or you can go to your local sexual 
health clinic. And we said, but we don't have the mon-
ey for them to do that, they can't come here routinely 
unless you're going to pay us for that. Public Health 
England, the screening people, they have the money 
to pay for the smears. But in all the moving around 
of the budgets, the money for smears that were taken 
outside general practice doesn't seem to be anywhere. 
[8384, local authority, Area 1, November 2015]
One participant from NHSE offered a different perspec-
tive. He argued that the public health budget of each 
local authority reflected the levels of cervical screening 
activity that had taken place in its sexual health clinics 
pre-HSCA. However, this is not clear because, in the past, 
the funding was not ‘disaggregated’ [4058, NHSE, Area 1, 
June 2015]. Therefore, it is not possible to establish what 
the pre-HSCA sexual health component of the public 
health budget covered.
…they (local authorities) think they’re not being 
paid for it (cervical screening). But, actually, in truth, 
whatever they were doing at the point of transition 
if they were doing loads of cervical smears they were 
just doing loads of cervical smears, so they had the 
money. There wasn’t a problem when they were doing 
them before, it’s just the money wasn’t disaggregated. 
However local authorities have been put under signif-
icant pressure in their public health teams to reduce 
their budgets. So these kinds of things are examples 
where you can say it’s not our responsibility so there-
fore we’re taking that element out. [4058, NHSE, 
Area 1, June 2015]
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The above quote illustrates a phenomenon reported by 
a number of participants that local authorities had repro-
cured their sexual health services and had taken a posi-
tion that they would not commission their sexual health 
provider(s) to do routine cervical screening, because it 
was not their commissioning responsibility. However, as 
one member of a screening team in Area 2 illustrated, 
NHSE was also reluctant to explicitly commission sexual 
health services to provide cervical screening, seemingly 
because of administrative challenges relating to numerous 
low-value contracts with providers:
So cervical screening, we could go to every sexual 
health provider and have a separate contract. The 
difficulty again becomes around commissioning ca-
pacity. So, I think we’ve got [x] local authorities, so 
we have [x] separate contracts all very low value, it’s 
about 1000 screens in each, so you’re talking maybe 
[x] £20 000 contracts or something. So, it’s a very bit-
ty way of doing stuff. So, we could still do it and we 
could pay for it, but in terms of the amount of pa-
perwork or the amount of outcomes it becomes po-
tentially unmanageable. [17685, PHE/NHSE, Area 2, 
December 2016]
This participant went on to indicate that he would 
prefer local authorities to commission cervical screening 
as part of their sexual health contracts, but acknowl-
edged the political difficulties for local authorities to 
justify spending money on an area of service that was not 
formally their responsibility, especially given the context 
of diminishing local authority budgets:
In a way, wouldn't it be so much easier if the local 
authorities just included it as part of their normal 
service? But their argument would be that’s not our 
role, and how can we defend to the (elected) council-
lors that we’re spending money on stuff that we don’t 
have to, that someone else is meant to be spending 
money on? And our argument is well, it’s just so much 
simpler and it’s not a lot of money. That’s the kind of 
discussion. And it eventually ends up with them with-
drawing money and us saying well, we’re not buying it 
either then. [17685, PHE/NHSE, Area 2, December 
2016]
Potential impacts on cervical screening rates
One local authority commissioner suggested that the 
policy of his local authority was to continue to facilitate 
opportunistic cervical screening tests at sexual health 
clinics, but not routine tests, because to provide the 
latter would have a detrimental impact on other sexual 
health services that the local authority was now obli-
gated to commission (“if we don't say no to (routine) 
smears, we'll be turning (other) people away, symp-
tomatic patients away, or women needing contracep-
tion away. And that's our duty" [8384, local authority, 
Area 1, November 2015]). He reported that local CCGs 
complained about this discontinuation of routine cervical 
screening at sexual health clinics, because there was insuf-
ficient capacity within general practice for CCGs to meet 
their cervical screening targets, and thus they required 
sexual health clinics to provide a proportion of cervical 
screening activity. One screening consultant developed 
this point by suggesting that some localities would see a 
substantial reduction in screening activity because of a 
lack of capacity within primary care:
…in some local authorities where the sexual health 
service is no longer doing cervical screening (it) will 
have a small impact but not a huge impact, in other 
areas, it will have a big impact on coverage, we’ll see 
activity go down around it, because the workload is 
just going to come straight back to primary care, and 
in different areas primary care didn’t realise this was 
happening, the re-commissioning, hasn’t got the ca-
pability and the capacity… [18352, PHE/NHSE, Area 
1, January 2017]
Another screening consultant reflected that changes to 
NHSE ‘footprints’ (ie, the abolition of Area Teams and 
the new, more regional focus of the organisation) had 
implications for the provision of cervical screening:
…say we wanted to sort out cervical screening cov-
erage in GP practices, in (name of PCT) you’ve 
got [x] GP practices, bottom 20 per cent you could 
talk to the [y] practices. In my new patch we’ve got 
(many more than x) practices. So you have to think 
in a completely different way. [17685, NHSE, Area 2, 
December 2016]
Several participants from different localities in both 
geographical areas pointed to long-standing challenges 
in ensuring good uptake rates for screening among their 
diverse local populations. There were concerns that 
these challenges would be exacerbated by a reduction in 
choice for women about where they could go for cervical 
screening tests:
…you should have an integrated sexual health ser-
vice where predominantly women can go in and get 
seen in one episode, in one place for all their sexual 
health needs, be that sexually transmitted infection 
testing and treatment and contraception. So I think 
probably in the past people worked very hard to get 
things like cervical screening into these services so 
that the needs of those women who perhaps wouldn't 
go to their local GP could be met in an environment 
they felt happy with. My feeling is now… that perhaps 
the type of women who traditionally would have gone 
for cervical screening (at their sexual health clinic) 
might not feel so comfortable in that environment 
(of the GP practice). So particularly, say, a lady from 
a South Asian background who goes to a single hand-
ed male GP with no practice nurse, that’s the kind of 
traditional person who might have gone to a family 
planning clinic for their cervical screening. [9742, lo-
cal authority, Area 2, January 2016]
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Summary
The HSCA separated commissioning responsibilities for 
some types of services, including sexual health. Our study 
participants told us that this had introduced complexity 
and confusion surrounding cervical screening commis-
sioning, and they expressed concern that screening rates 
would decline as a result, with some areas potentially 
affected more than others due to differences in local 
contextual conditions. In order to explore this further, 
we designed a quantitative analysis to test the proposition 
that CCGs most affected by this increase in complexity 
would have a greater decline in screening rates. Based on 
the findings from our interviews that working with more 
than one local authority acted to increase the complexity 
associated with the commissioning role, we compared 
screening rates between those CCGs which relate to a 
single local authority and those required to work with two 
or more local authorities.
Quantitative findings
There were 14.1 million women eligible for screening in 
England in 2016.21 Cervical screening rates decreased 
over time and the decline predated the implementation 
of the HSCA in April 2013. Unassisted delivery rates also 
declined over time. The relative decline between the first 
year (2009–10) and the last year (2015–16) for unassisted 
deliveries (−4.17%) was larger than for cervical screening 
(−2.70%) (table 3).
The changes in cervical screening rates over time 
were similar for practices in CCGs dealing with a single 
local authority (−2.53%) compared with practices in 
CCGs working with multiple local authorities (−2.87%). 
Figure 1 illustrates the trends in rates of cervical screening 
in the preintervention and postintervention periods for 
CCGs depending on the number of local authorities they 
worked with. There is a noticeable and sharp decline in 
the rates in both groups between 2011–12 and 2012–13.
Comparing the unadjusted averages for the pre-HSCA 
and post-HSCA years, cervical screening rates decreased 
by 0.39% more for GP practices located in CCGs working 
with multiple local authorities compared with practices 
in CCGs working with a single local authority. Unassisted 
birth rates decreased by 0.40% less for GP practices in 
CCGs working with multiple local authorities compared 
with GP practices in CCGs working with a single local 
authority. As maternity services were largely unaffected 
by the HSCA, we assumed that these differential changes 
captured the unmeasured population influences that 
confound comparisons of the changes in the two groups 
of CCGs. Relative to the decreases in unassisted delivery 
rates, GP practices in CCGs working with multiple local 
authorities experienced a decrease in cervical screening 
rates of 0.79% compared with practices in CCGs working 
with a single local authority (table 4).
The results were qualitatively similar when we estimated 
the formal triple difference (for all years and 2011–12 
onwards only) and lagged dependent variable regression 
models (table 5). The triple-difference estimates show 
Table 3 Numbers of general practices and mean rates of cervical screening and unassisted deliveries by year and by the 
number of LAs with which CCGs had to coordinate commissioning
Year
Number of general practices Cervical screening rate (%) Unassisted delivery rate (%)
 1 LA 2+ LAs All 1 LA 2+ LAs All 1 LA 2+ LAs All
2009–10 4260 3399 7659 82.85 84.74 83.75 63.44 63.8 63.59
2010–11 4261 3403 7664 82.74 84.61 83.63 63.19 63.76 63.44
2011–12 4260 3400 7660 81.49 83.13 82.27 62.41 63.61 62.94
2012–13 4249 3399 7648 81.28 82.87 82.04 62.17 63.08 62.57
2013–14 4199 3355 7554 81.31 82.5 81.88 61.33 62.43 61.82
2014–15 4125 3302 7427 81.21 82.54 81.85 60.67 61.98 61.25
2015–16 4026 3236 7262 80.75 82.31 81.49 60.47 61.53 60.94
Relative change between 2009–10 and 2015–16 
(%)
−2.53 −2.87 −2.70 −4.68 −3.56 −4.17
Mean cervical screening and unassisted delivery rates are weighted by the denominators used in the calculation of the rates. These are the 
eligible populations; the number of women aged between 25 and 64 years or the number of maternal deliveries.
CCG, Clinical Commissioning Group; LA, local authority. 
Figure 1 Uptake (%) of cervical screening pre-HSCA 
and post-HSCA. HSCA, Health and Social Care Act 2012; 
LA, local authority.
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that there was a differentially larger decline of 0.62% 
(95% CI −0.941 to −0.297) (model 1) in cervical screening 
rates for practices located in CCGs working with more 
than one local authority. The decrease is smaller using 
the shorter preperiod (0.259%; 95% CI −0.573 to 0.052, 
model 2).
The direction of result is robust to the model spec-
ification and, although we rejected the assumption of 
parallel trends for model 1 (all years), we could not reject 
the assumption for model 2 (2011–12 onwards). We also 
found a similar result in model 3 using the lagged depen-
dent variable estimator, which yields unbiased estimates 
when pretrends cannot be assumed to be parallel.
The results are also robust to different groupings of the 
number of local authorities that CCGs work with. Table 5 
includes model estimates comparing CCGs working with 
one or two local authorities with CCGs working with 
more than two local authorities. The direction of results 
is equivalent; and the scale and significance are either 
equivalent or increased. The same pattern is repeated in 
terms of tests of parallel trends. We cannot reject the null 
hypothesis of parallel trends for model 2 and the LDV 
estimation is preferable to model 1 in which we can reject 
the null hypothesis of parallel trends.
dIsCussIOn
We conducted a mixed methods study exploring the 
impact of changes associated with the HSCA in the 
English NHS on cervical screening rates. We carried out 
qualitative interviews with senior figures from a variety 
of relevant organisations in two large, socioeconomically 
diverse areas of England. Analysis of these interviews 
suggested that cervical screening commissioning had 
become more complex, with responsibilities between 
organisations less certain, as a consequence of the 
HSCA. Some interviewees predicted there would be a 
reduction in cervical screening rates in particular areas. 
Table 4 Rates of cervical screening and unassisted birth for CCGs working with one and more than one LA, before and after 
the introduction of the HSCA
Condition
CCGs working with one LA CCGs working with more than one LA Difference between 
change in CCGs 
working with more 
than one LA and 
change in CCGs 
working with one LA
Difference in 
changes for 
cervical screening 
minus difference 
in changes for 
unassisted births
Average 
in the pre-
HSCA years
Average in 
the post-
HSCA years Change
Average 
in the pre-
HSCA years
Average in 
the post-
HSCA years Change
Per cent
Affected (cervical 
screening rates)
82.09 81.09 −1.00 83.84 82.45 −1.39 -0.39 0.78
Unaffected 
(unassisted birth rates)
62.80 60.82 −1.98 63.56 61.98 −1.58 0.40
Values for pre and post are averages for all years in pre and post periods. The averages are weighted by the denominators used in the calculation of 
the rates. These are the eligible populations; the number of women aged between 25 and 64 years or the number of maternal deliveries.
CCG, Clinical Commissioning Group; HSCA, Health and Social Care Act 2012;  LA, local authority.
Table 5 Triple-difference regression results
Difference-in-differences models
Lagged dependent variable 
models 
All years (1) 2011–12 onwards (2) All years (3)
Coefficient 95% CI Coefficient 95% CI Coefficient 95% CI
Triple differences −0.617 −0.941 to  −0.297 −0.259 −0.573 to  0.052 −0.238 −0.446 to  −0.031
Triple differences(alternative 
grouping of CCGs)
−0.774 −1.134 to  −0.420 −0.440 −0.786 to  −0.099 −0.234 −0.461 to  −0.009
Number of observations 105 745 75 099 44 472
Test of parallel trends F(3, 7672) P value F(1, 7667) P value N/A
  4.89 0.002 0.33 0.567
Values are regression estimations from weighted least squares models on the empirical logit transformation of the rate including 
practice condition-specific fixed effects, full interaction of year with condition; and full interaction of year with the dummy for (N of 
LAs). Weighted by the denominators used to calculate the rates. Robust SEs, clustered by practice.
The triple difference represents (the change over time in cervical screening rates for CCGs working with only one LA minus the 
change over time in cervical screening rates for CCGs working with more than one LA) minus (the change over time in unassisted 
birth rates for CCGs working with only one LA minus the change over time in unassisted birth rates for CCGs working with more than 
one LA).
This model uses an alternative grouping of CCGs based on the number of LAs they work with ([1 or 2] vs [>2]).
LDV also contains values of the dependent variable in each of the pre intervention years. Estimated only on post intervention years. 
CCG, Clinical Commissioning Group; LA, local authority; N/A, not available.   
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These findings prompted the development of an anal-
ysis to explore these issues quantitatively via a triple-dif-
ference regression analysis of publicly available data on 
cervical screening activity. To control for unmeasured 
confounders, we compared cervical screening rates with 
trends in unassisted birth rates because the commis-
sioning of maternity services was unchanged pre-HSCA 
and post-HSCA.
Interviewees suggested a number of factors that 
might contribute to a reduction in cervical screening 
activity. Sexual health service commissioning respon-
sibility had shifted to local authorities while NHSE was 
made responsible for commissioning national screening 
services, including cervical screening. Faced with finan-
cial austerity and cuts to their budgets, many local author-
ities were retendering their sexual health services with 
sexual health service providers but not including routine 
cervical screening. NHSE was also seemingly reluctant 
to commission sexual health clinics to perform cervical 
screening tests because this would entail a multitude of 
low-value contracts with numerous providers. This would 
be administratively laborious and practically difficult 
given the large size of NHSE’s administrative areas and 
small numbers of NHSE commissioning staff in each area.
The quantitative analysis was designed to explore 
whether cervical screening activity had declined in areas 
most affected by commissioning organisational change. 
GP practices located in CCGs dealing with multiple local 
authorities, and therefore most exposed to increased 
commissioning complexity and potential disruption 
in services because of the lack of clarity of the roles of 
different organisations, experienced a larger decrease 
over time in cervical screening rates compared with 
practices in CCGs dealing with a single local authority. 
The opposite pattern was observed for unassisted births, 
which decreased more over time in the CCGs dealing 
with a single local authority. The triple-difference anal-
yses confirmed that the effects were statistically significant 
and robust to different model specifications.
We have demonstrated unintended consequences 
arising out of a large-scale health system reform. Taken 
together, our findings suggest that there is an urgent need 
for clarification as to who holds the budget, and there-
fore who should be commissioning, cervical screening 
in the English NHS, and for local agreements to ensure 
that issues over funding and budgets do not disrupt 
screening programmes. More broadly, the issues we 
have identified in this study are of value to policy makers 
and system leaders in other health systems. The current 
study suggests that there are particular problems associ-
ated with service commissioning where coordination is 
required between multiple commissioners. This suggests 
that future commissioning reforms should include 
assessment of the likely impact on coordination, and a 
presumption in favour of commissioning all required 
services for geographical populations where possible. 
This may also have implications for mixed health systems, 
in which multiple payers (including public and private 
insurers as well as out of pocket payments) are respon-
sible for services. In such systems achieving desirable 
population coverage for services such as screening may 
require specific coordination efforts.
Potential confounders and study strengths
We took 2009 as our starting point for pre-HSCA cervical 
screening activity. Two potential confounders to our 
results were considered. First, the high-profile case of 
Jade Goody, a reality TV star who was diagnosed with 
cervical cancer in August 2008 and died in March 2009. 
The contemporaneous media attention and publicity was 
linked with a substantial increase in cervical screening 
rates (around an extra half a million women) during the 
time between Goody’s diagnosis and death. However, 
previous impacts of high-profile cases of celebrity cancer 
diagnoses on population behaviour have tended to be 
brief and immediate rather than longer-lasting, and, 
therefore, we are confident that from 2010, rates of 
cervical screening returned towards underlying trends.22 
Second, the UK’s Human Papillomavirus (HPV) vacci-
nation programme was introduced in 2008 in order to 
reduce the incidence of cervical cancer.23 The vaccine 
is offered to all girls aged 12–13 years, and figures for 
2008–14 show high uptake rates of just under 90%. It is 
likely that this vaccination programme will contribute 
to a reduction in cervical screening activity in future. 
However, the first cohort of women in the programme, 
that is, those aged 12–13 years in 2008, were aged only 
21–22 years in 2016–17, hence too young to have been 
invited for routine cervical screening (which begins at age 
25) at the time of the study. We can, therefore, be confi-
dent that any changes to cervical screening rates cannot 
yet be attributed directly to the HPV programme, but any 
future research into cervical screening rates needs to take 
this into account.
We considered whether the results were sensitive to the 
group of CCGs in terms of the number of local author-
ities they worked with. The direction of results was the 
same, and the strength and significance was increased, 
comparing CCGs working with one or two local author-
ities with those CCGs working with more than two local 
authorities. We also considered whether the results were 
sensitive to the choice of comparison indicator (unas-
sisted births) for maternity services. We tested whether 
the results would hold for another indicator of maternity 
services: the rate of deliveries by caesarean section. We 
observed the same direction and significance of results 
for this indicator as well.
The average age of mothers at delivery is likely to be 
younger than the average age of women attending for 
cervical screening. For our analysis, we require that differ-
ential changes in maternity indicators between CCGs 
with simple and CCGs with complex local authority rela-
tionships are a good proxy for other factors influencing 
cervical screening rates. We have confirmed the empirical 
validity of this assumption by looking for parallel trends in 
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the period before the HSCA, but we can never be entirely 
sure of its validity.
The findings presented here come from a longitudinal 
study of major healthcare system reform conducted by 
a multidisciplinary research team. The nature of this 
study facilitated the development of the relatively novel, 
sequential mixed methods approach in which the claims 
made in qualitative interviews could be tested in a subse-
quent quantitative analysis. There is a reinforcing effect 
in this analytical approach, which provides a strong 
cumulative indication that in areas of the country where 
complexity and coordination issues linked to the HSCA 
were more likely to occur there was an associated reduc-
tion in cervical screening rates.
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